Search Results: MCHLine

Annotation: This report brings together a growing body of scientific research demonstrating substantial disparities in pharmaceutical therapy for Hispanic Americans. The report discusses disparities in relation to asthma and Hispanic children, mental illness, and status of research; genetics and individualized response to drugs in Hispanics in relation to asthma, diabetes, heart attack, and Alzheimers disease; clinical implications of variations in genes regulating drug metabolism; undertreatment of coexisting conditions; and communication, culture, and implications of optimal pharmaceutical care. Statistical information is presented in figures throughout the report. The report includes conclusions, recommendations, and references.

• PDF

Keywords: Alzheimers disease, Asthma, Children, Communication, Cultural factors, Culture, Diabetes, Drug therapy, Genetics, Heart diseases, Hispanic Americans, Mental disorders, Pharmaceuticals, Research, Treatment

Annotation: This electronic resource provides a database of pharmaceutical and medical abbreviations and acronyms, plus a database of pharmaceutical companies, medical associations, hospitals, drugs, equipment, ICD9 codes. Links to a variety of medical and health resources are also provided.

• Link

Keywords: Clinical coding, Acronyms, Dictionaries, Drugs, Electronic publications, Medical reference books, Online databases, Pharmaceuticals

• PDF

Keywords: Managed care, Medicaid, Pharmaceutical fees, Pharmaceuticals, State programs

Annotation: This book provide the texts of the presentations at a conference on biomedical research and orphan medicinal products. Section one addresses rare diseases. Section two discusses related research and development. Section three discusses legislation regarding orphan medicinal products. Section four discusses the related ethical aspects. And section five provides the related discussion of the conference.

Keywords: Conferences, Ethics, Europe, Legislation, Orphan drugs, Pharmaceuticals, Rare diseases, Research

Annotation: This issue brief discusses legislation on Medicaid managed care that has at least passed one house of state legislatures. The summaries provided are not meant to be comprehensive, but to highlight certain issues and to give an overview of the trends that are emerging so far this year in terms of Medicaid managed care. Summaries are provided regarding creating or expanding Medicaid managed care programs, Medicaid managed care, caution on managed care for the elderly and persons with disabilities, oversight of managed care organizations and setting criteria for health maintenance organizations, protections for Medicaid managed care recipients, ensuring quality of care, Medicaid managed care fraud, and pharmaceuticals. Summaries are provided for legislation in California, Colorado, Connecticut, Florida, Hawaii, Illinois, Indiana, Kansas, Louisiana, Maryland, Michigan, Minnesota, Mississippi, Nevada, New Jersey, New Mexico, New York, North Dakota, Oklahoma, Oregon, Pennsylvania, Rhode Island, Tennessee, Texas, Virginia, and Washington. This information is current through September 25, 1997.

Keywords: California, Colorado, Connecticut, Disabilities, Disabilities, Florida, Fraud, Hawaii, Health maintenance organizations, Illinois, Indiana, Kansas, Louisiana, Managed care, Maryland, Medicaid managed care, Michigan, Minnesota, Mississippi, Nevada, New Jersey, New Mexico, New York, North Dakota, Oklahoma, Older adults, Oregon, Pennsylvania, Pharmaceuticals, Quality assurance, Rhode Island, Special health care needs, State legislation, Tennessee, Texas, Virginia, Washington